#Sweden #AGM #Stockholm #RaySearch Laboratories

RaySearch Laboratories Annual General Meeting 2025

On May 22, 2025, RaySearch Laboratories AB (publ) convened its Annual General Meeting (AGM) in Stockholm, Sweden. The event was pivotal for shareholders as it addressed several significant resolutions that shape the future governance and financial management of the company.

Board Member Re-Elections

One of the key outcomes of the AGM was the re-election of several board members. Carl Filip Bergendal, Johan Löf, Günther Mårder, Britta Wallgren, and Hans Wigzell were all confirmed to continue serving on the board, ensuring stability and continuity in leadership. Notably, Hans Wigzell was once again appointed as Chairman of the Board, which highlights the confidence that shareholders have in his leadership.

Dividends and Financial Performance

During the meeting, the balance sheets and income statements presented were approved, and the board members, along with the CEO, were discharged from liability for the past fiscal year. Reflecting a positive financial outlook, the attendees voted in favor of a dividend payment of SEK 3 per share, with the record date set for May 26, 2025. The remaining accumulated profit of SEK 187,755,281 will be carried forward for future financial periods, showcasing the company's robust position in the market.

Remuneration for Board Members

The AGM resolved to set the remuneration for board members who do not draw a salary from any Group company. This includes a significant compensation of SEK 840,000 for the Chairman of the Board and SEK 300,000 for each other board member. Such arrangements indicate the company’s commitment to attracting and retaining top talents at the governance level.

Auditors and Governance Reports

Moreover, the meeting confirmed the re-appointment of Deloitte AB as the company’s auditor until the next AGM. The auditor's fees will be covered in accordance with their invoicing, ensuring transparency in the financial oversight of RaySearch Laboratories. The AGM also approved the Board's remuneration report for the year 2024 and endorsed the proposed guidelines regarding executive remuneration, highlighting the company’s focus on aligning management incentives with shareholder interests.

RaySearch Laboratories' Innovations

RaySearch Laboratories is recognized for its innovative contributions to medical technology, particularly in software solutions aimed at improving cancer treatment. The company markets various products including the RayStation® treatment planning system and RayCare® oncology information system. Recent additions like RayIntelligence® and RayCommand® further exemplify its commitment to enhancing operational efficiency in cancer clinics worldwide.

Founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and publicly listed on Nasdaq Stockholm since 2003, RaySearch has positioned itself as a leader in oncology software, serving more than 1,100 clinics across 47 countries.

In summary, the Annual General Meeting of RaySearch Laboratories in 2025 marked a significant milestone in steering the company towards a future of sustained growth and innovation. The decisions taken reflect a transparent, accountable, and strategic approach to corporate governance geared towards enhancing shareholder value and pioneering advancements in cancer treatment technology.

For more detailed information regarding the AGM and future developments, the company has made comprehensive reports available on their official website.